The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Computational Approaches for the Discovery of Novel Hepatitis C Virus NS3/4A and NS5B Inhibitors
|
Author(s): Khac-Minh Thai (University of Medicine and Pharmacy at HCMC, Vietnam), Quoc-Hiep Dong (University of Medicine and Pharmacy at HCMC, Vietnam), Thi-Thanh-Lan Nguyen (University of Medicine and Pharmacy at HCMC, Vietnam), Duy-Phong Le (University of Medicine and Pharmacy at HCMC, Vietnam), Minh-Tri Le (University of Medicine and Pharmacy at HCMC, Vietnam)and Thanh-Dao Tran (University of Medicine and Pharmacy at HCMC, Vietnam)
Copyright: 2017
Pages: 37
Source title:
Oncology: Breakthroughs in Research and Practice
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/978-1-5225-0549-5.ch017
Purchase
|
Abstract
Nonstructural 5B (NS5B) polymerase and Nonstructural 3/4A (NS3/4A) protease have proven to be promising targets for the development of anti-HCV (Hepatitis C Virus) agents. The NS5B polymerase is of paramount importance in HCV viral replication; therefore, employing NS5B inhibitors was considered an effective way for the treatment of HCV. Identifying inhibitors against NS3/4A serine protease represents another attractive approach applied in anti-HCV drug discovery, which is evidenced by its crucial role of in the biogenesis of the viral replication activity. In this chapter, many different computational approaches including Quantitative Structure-Activity Relationship (QSAR) and virtual screening in anti-HCV drug discovery were considered and discussed in detail. Virtual Screening (VS) techniques, including ligand-based and structure-based, and QSAR have been utilized for the discovery of NS5B inhibitors. Moreover, using various in silico protocols and workflows, a number of studies have been conducted with an aim of identifying potential NS3/4A blockage agents.
Related Content
Genevieve Z. Steiner-Lim, Madilyn Coles, Kayla Jaye, Najwa-Joelle Metri, Ali S. Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan Russo, Tim Karl.
© 2023.
47 pages.
|
Mohd Kashif, Mohammad Waseem, Poornima D. Vijendra, Ashok Kumar Pandurangan.
© 2023.
28 pages.
|
Courtney R. Acker, Rana R. Zeine.
© 2023.
27 pages.
|
Mahesh Pattabhiramaiah, Shanthala Mallikarjunaiah.
© 2023.
16 pages.
|
Dhairavi Shah, Dhaara Shah, Yara Mohamed, Danna Rosas, Alyssa Moffitt, Theresa Hearn Haynes, Francis Cortes, Taunjah Bell Neasman, Phani kumar Kathari, Ana Villagran, Rana R. Zeine.
© 2023.
28 pages.
|
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar, Shahid Bashir.
© 2023.
23 pages.
|
Akila Muthuramalingam, Ashok Kumar Pandurangan, Subhamoy Banerjee.
© 2023.
17 pages.
|
|
|